Reduction in Arterial Stiffness With Angiotensin II Antagonism and Converting Enzyme Inhibition. A Comparative Study Among Malay Hypertensive Subjects With a Known Genetic Profile

American Journal of Hypertension

Volumn 20, Issue 2, 2007, Pages 184-189

  Rehman, Asia ^a   Ismail, Shaiful Bahari ^b   Naing, Lin ^a   Roshan, Tariq Mahmood ^b   Rahman, Abdul Rashid Abdul ^c  

^a SCHOOL OF PHYSICS   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c CYBERJAYA UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Aortic stiffness; gene polymorphism; hypertension; losartan; prindopril; pulse wave velocity; renin angiotensin system

Indexed keywords

ADENINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; CYTOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; PERINDOPRIL;

ADULT; ARTERY COMPLIANCE; ARTERY STIFFNESS; ARTICLE; ASIAN; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD VESSEL PARAMETERS; BORDERLINE HYPERTENSION; CAROTID ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG RESPONSE; ENZYME INHIBITION; FEMALE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HYPERTENSION; LONG TERM CARE; MALAYSIA; MALE; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AORTA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALAYSIA; MALE; PERINDOPRIL; POLYMORPHISM, GENETIC; PULSE; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 33846438982     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.07.015     Document Type: Article

References (31)

1. Safar M.E. Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 10 (2001) 257-261
2. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., Ducimetiere P., and Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
3. Yongbin N.I., Wang H., Dayi H.U., and Zhang W. The relationship between pulse wave velocity and pulse pressure in Chinese patients with essential hypertension. Hypertens Res 26 (2003) 871-874
4. Boutouyrie P., Tropeano A.I., Asmar R., Gautier I., Benetos A., Lacolley P., and Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39 (2002) 10-15
5. Laurent S., Katsahian S., Fassot C., Tropeano A.I., Gautier I., Laloux B., and Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 34 (2003) 1203-1206
6. Asmar R., Benetos A., London G., Hugue C., Weiss Y., Topouchian J., Laloux B., and Safar M. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press 4 (1995) 48-54
7. Benetos A., Cambien F., Gautier S., Ricard S., Safar M., Laurent S., Lacolley P., Poirier O., Topouchian J., and Asmar R. Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 28 (1996) 1081-1084
8. Guerin A.P., London G.M., Marchais S.J., and Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15 (2000) 1014-1021
9. Mahmud A., and Feely J. Effect of angiotensin II receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens 15 (2002) 1092-1095
10. Mahmud A., and Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens 15 (2002) 321-325
11. Paillard F., Chansel D., Brand E., Benetos A., Thomas F., Czekalski S., Ardaillou R., and Soubrier F. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 34 (1999) 423-429
12. 1 receptors. J Hum Hypertens 16 (2002) 261-266
13. Rehman A., Rahman A.R., Rasool A.H., and Naing N.N. The effects of angiotensin II on pulse wave velocity in healthy humans. Int J Clin Pharmacol Ther 39 (2001) 423-430
14. Dupont W.D., and Plummer W.D. Power and sample size calculations for studies involving linear regression. Control Clin Trials 19 (1998) 589-601
15. Yang H., Deng Y., Li C., Bi X., Pan M., and Chang Q. Assessment of effect of angiotensin II receptor antagonist losartan on aortic distensibility in patients with essential hypertension by echocardiography. J Huazhong Univ Sci Technolog Med Sci 22 (2002) 164-167
16. Klemsdal T.O., Moan A., and Kjeldsen S.E. Effects of selective angiotensin II type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension. Blood Press 8 (1999) 214-219
17. Miller J.A., Thai K., and Scholey J.W. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II. Kidney Int 56 (1999) 2173-2180
18. Asmar R., Topouchian J., Pannier B., Benetos A., and Safar M. Pulse wave velocity as endpoint in large-scale intervention trial. The COMPLIOR study. Scientific, quality control, coordination and investigation committees of the COMPLIOR study. J Hypertens 19 (2001) 813-818
19. Manolis A.J., Iraklianou S., Pittaras A., Zaris M., Tsioufis K., Psaltiras G., Psomali D., Foussas S., Gavras I., and Gavras H. Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy. Am J Hypertens 18 (2005) 18-22
20. Rajzer M., Klocek M., and Kawecka-Jaszcz K. Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension. Am J Hypertens 16 (2003) 439-444
21. Benetos A., Levy B.I., Lacolley P., Taillard F., Duriez M., and Safar M.E. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 17 (1997) 3196-3201
22. 1 receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler Thromb Vasc Biol 19 (1999) 1843-1851
23. Benetos A., Gautier S., Lafleche A., Topouchian J., Frangin G., Girerd X., Sissmann J., and Safar M.E. Blockade of angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humans. J Vasc Res 37 (2000) 8-15 discussion 68-70
24. Takami T., and Shigemasa M. Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 26 (2003) 609-614
25. Hornig B., Landmesser U., Kohler C., Ahlersmann D., Spiekermann S., Christoph A., Tatge H., and Drexler H. Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase. Circulation 103 (2001) 799-805
26. 1 receptor blockade on endothelial function in essential hypertension. Am J Hypertens 16 (2003) 123-128
27. Laurent S., Kingwell B., Bank A., Weber M., and Struijker-Boudier H. Clinical applications of arterial stiffness: therapeutics and pharmacology. Am J Hypertens 15 (2002) 453-458
28. Ludwig M., Stapff M., Ribeiro A., Fritschka E., Tholl U., Smith R.D., and Stumpe K.O. Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin Ther 24 (2002) 1175-1193
29. Schiffrin E.L., Park J.B., Intengan H.D., and Touyz R.M. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101 (2000) 1653-1659
30. 1 receptor A1166C polymorphisms. A pharmacogenomic approach. Am J Hypertens 16 (2003) 18A
31. Redon J., Luque-Otero M., Martell N., and Chaves F.J. Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients. Pharmacogenomics J 5 (2005) 14-20